1. Home
  2. ONEW vs ADCT Comparison

ONEW vs ADCT Comparison

Compare ONEW & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$9.74

Market Cap

155.3M

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$3.80

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
ADCT
Founded
2014
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.3M
484.4M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
ONEW
ADCT
Price
$9.74
$3.80
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$16.75
$7.75
AVG Volume (30 Days)
151.9K
802.9K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.86
EPS
2.77
N/A
Revenue
$1,872,334,000.00
$81,357,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.27
$68.29
P/E Ratio
$3.41
N/A
Revenue Growth
5.62
14.85
52 Week Low
$8.12
$1.05
52 Week High
$17.92
$4.98

Technical Indicators

Market Signals
Indicator
ONEW
ADCT
Relative Strength Index (RSI) 48.63 43.34
Support Level $8.12 $3.65
Resistance Level $9.83 $3.87
Average True Range (ATR) 0.62 0.21
MACD 0.19 -0.05
Stochastic Oscillator 95.82 22.50

Price Performance

Historical Comparison
ONEW
ADCT

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: